NFIB
Basic information
Region (hg38): 9:14081843-14398983
Links
Phenotypes
GenCC
Source:
- macrocephaly, acquired, with impaired intellectual development (Moderate), mode of inheritance: AD
- macrocephaly, acquired, with impaired intellectual development (Strong), mode of inheritance: AD
- macrocephaly, acquired, with impaired intellectual development (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Macrocephaly, acquired, with impaired intellectual development | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 30388402 |
ClinVar
This is a list of variants' phenotypes submitted to
- Macrocephaly, acquired, with impaired intellectual development (9 variants)
- not provided (4 variants)
- Macrocephaly;Intellectual disability (4 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NFIB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 55 | 69 | ||||
nonsense | 11 | |||||
start loss | 1 | |||||
frameshift | 13 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 4 | 2 | 6 | |||
non coding | 6 | |||||
Total | 12 | 18 | 66 | 13 | 0 |
Variants in NFIB
This is a list of pathogenic ClinVar variants found in the NFIB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-14088120-T-A | Likely benign (Jul 01, 2024) | |||
9-14088211-C-G | Macrocephaly, acquired, with impaired intellectual development | Uncertain significance (Apr 24, 2020) | ||
9-14088248-G-A | NFIB-related disorder | Likely benign (Mar 02, 2023) | ||
9-14113001-G-A | Macrocephaly, acquired, with impaired intellectual development | Likely pathogenic (Mar 26, 2024) | ||
9-14113018-G-T | Inborn genetic diseases | Uncertain significance (Jan 10, 2023) | ||
9-14113043-C-T | NFIB-related disorder | Uncertain significance (Jul 11, 2023) | ||
9-14113076-T-C | Inborn genetic diseases | Uncertain significance (Jan 31, 2024) | ||
9-14116247-T-G | Inborn genetic diseases | Uncertain significance (Dec 03, 2021) | ||
9-14116262-G-A | Uncertain significance (Feb 13, 2019) | |||
9-14116286-G-T | Macrocephaly, acquired, with impaired intellectual development | Uncertain significance (Jul 17, 2023) | ||
9-14116300-G-C | NFIB-related disorder • Inborn genetic diseases | Likely benign (Dec 14, 2023) | ||
9-14116312-G-A | Inborn genetic diseases | Uncertain significance (Aug 01, 2024) | ||
9-14116313-G-A | Inborn genetic diseases | Uncertain significance (Feb 09, 2024) | ||
9-14116328-C-G | NFIB-related disorder | Likely benign (Apr 01, 2024) | ||
9-14116333-C-T | NFIB-related disorder | Uncertain significance (May 09, 2024) | ||
9-14120468-T-C | Macrocephaly, acquired, with impaired intellectual development | Uncertain significance (Jan 21, 2021) | ||
9-14120480-T-C | Inborn genetic diseases | Uncertain significance (May 01, 2022) | ||
9-14120502-G-C | Uncertain significance (Oct 25, 2022) | |||
9-14120538-A-G | Macrocephaly, acquired, with impaired intellectual development | Uncertain significance (Mar 09, 2020) | ||
9-14120548-C-T | Likely benign (Dec 01, 2023) | |||
9-14120549-G-C | Macrocephaly, acquired, with impaired intellectual development | Uncertain significance (Jan 14, 2021) | ||
9-14120554-G-A | Likely benign (Jun 18, 2018) | |||
9-14120564-A-G | Uncertain significance (May 03, 2019) | |||
9-14120567-A-C | not specified | Uncertain significance (May 01, 2024) | ||
9-14120598-G-A | Inborn genetic diseases | Uncertain significance (Sep 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NFIB | protein_coding | protein_coding | ENST00000380953 | 11 | 317141 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00139 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.47 | 151 | 264 | 0.572 | 0.0000139 | 3206 |
Missense in Polyphen | 64 | 154.58 | 0.41402 | 1886 | ||
Synonymous | -1.38 | 114 | 96.7 | 1.18 | 0.00000530 | 990 |
Loss of Function | 4.55 | 2 | 27.9 | 0.0716 | 0.00000174 | 294 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Recognizes and binds the palindromic sequence 5'- TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication.;
- Pathway
- Pathways Affected in Adenoid Cystic Carcinoma;Gene expression (Transcription);RNA Polymerase III Transcription Termination;FOXA1 transcription factor network;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription
(Consensus)
Recessive Scores
- pRec
- 0.419
Intolerance Scores
- loftool
- 0.0759
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24
Haploinsufficiency Scores
- pHI
- 0.945
- hipred
- Y
- hipred_score
- 0.808
- ghis
- 0.626
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.811
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nfib
- Phenotype
- respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;chondrocyte differentiation;DNA replication;response to bacterium;glial cell differentiation;principal sensory nucleus of trigeminal nerve development;anterior commissure morphogenesis;hindbrain development;positive regulation of transcription by RNA polymerase II;Clara cell differentiation;type I pneumocyte differentiation;type II pneumocyte differentiation;salivary gland cavitation;cell differentiation involved in salivary gland development;lung ciliated cell differentiation;commissural neuron axon guidance;negative regulation of pri-miRNA transcription by RNA polymerase II;negative regulation of mesenchymal cell proliferation involved in lung development;negative regulation of epithelial cell proliferation involved in lung morphogenesis
- Cellular component
- fibrillar center;nucleus;cerebellar mossy fiber
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding